241 related articles for article (PubMed ID: 27723629)
1. GSTM1 null polymorphism prevalence in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction study.
Tanwar R; Iyengar AR; Nagesh KS; Patil S; Subhash BV
Indian J Dent Res; 2016; 27(4):353-358. PubMed ID: 27723629
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of glutathione S-transferase M1 null polymorphism in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction study.
Tanwar R; Iyengar AR; Nagesh KS; Patil S; Subhash BV
Contemp Clin Dent; 2015 Mar; 6(Suppl 1):S59-64. PubMed ID: 25821378
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers.
Nair UJ; Nair J; Mathew B; Bartsch H
Carcinogenesis; 1999 May; 20(5):743-8. PubMed ID: 10334189
[TBL] [Abstract][Full Text] [Related]
5. GSTM1 polymorphism and oral leukoplakia.
Duarte EC; da Silva MS; Gomez MV; Gomez RS
J Oral Pathol Med; 2006 Apr; 35(4):202-5. PubMed ID: 16519766
[TBL] [Abstract][Full Text] [Related]
6. GSTM1 null polymorphism and palmar dermatoglypics in oral leukoplakia.
Yogesh L; Aswath N
Indian J Dent Res; 2021; 32(1):69-73. PubMed ID: 34269240
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers.
Sikdar N; Paul RR; Roy B
Int J Cancer; 2004 Mar; 109(1):95-101. PubMed ID: 14735473
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population.
Yadav DS; Devi TR; Ihsan R; Mishra AK; Kaushal M; Chauhan PS; Bagadi SA; Sharma J; Zamoawia E; Verma Y; Nandkumar A; Saxena S; Kapur S
Genet Test Mol Biomarkers; 2010 Oct; 14(5):715-23. PubMed ID: 20854097
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.
Shukla D; Dinesh Kale A; Hallikerimath S; Vivekanandhan S; Venkatakanthaiah Y
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Sep; 156(3):253-9. PubMed ID: 22660220
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
11. GSTT1 polymorphism and oral leukoplakia.
Barroso Duarte EC; Da Silva MS; Gomez MV; Gomez RS
Anticancer Res; 2006; 26(1A):427-30. PubMed ID: 16475728
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
13. Tobacco, antioxidant enzymes, oxidative stress, and genetic susceptibility in oral cancer.
Patel BP; Rawal UM; Rawal RM; Shukla SN; Patel PS
Am J Clin Oncol; 2008 Oct; 31(5):454-9. PubMed ID: 18838881
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
15. Association of Glutathione-S-Transferases M1 and T1 Deletional Variants with Development of Oral Squamous Cell Carcinoma: A Study in the South-East of Iran.
Saravani S; Miri-Moghaddam M; Bazi A; Miri-Moghaddam E
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1921-1926. PubMed ID: 31244319
[TBL] [Abstract][Full Text] [Related]
16. Association of mitochondrial D-loop mutations with GSTM1 and GSTT1 polymorphisms in oral carcinoma: a case control study from northeast India.
Mondal R; Ghosh SK; Talukdar FR; Laskar RS
Oral Oncol; 2013 Apr; 49(4):345-53. PubMed ID: 23265943
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population.
Buch SC; Notani PN; Bhisey RA
Carcinogenesis; 2002 May; 23(5):803-7. PubMed ID: 12016153
[TBL] [Abstract][Full Text] [Related]
18. Role of CYP2E1 genetic polymorphism in the development of oral leukoplakia among tobacco users in North Indian population.
Gupta S; Gupta OP; Srivastava S
Indian J Cancer; 2014; 51(2):154-8. PubMed ID: 25104199
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk.
Anantharaman D; Samant TA; Sen S; Mahimkar MB
Oral Oncol; 2011 Sep; 47(9):866-72. PubMed ID: 21741876
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymorphisms in XRCC1, CCND1 and GSTM1 and tobacco exposure as risk modifier for oral leukoplakia.
Yadav BK; Kaur J; Srivastava A; Ralhan R
Int J Biol Markers; 2009; 24(2):90-8. PubMed ID: 19634112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
